In this article, we derive the limit of detection for a two-step molecular recognition process and show that in-spite of all the recognition reactions being in equilibrium the overall error rates can be reduced exactly as much as possible in non-equilibrium methods such as kinetic proofreading.
Similar to biological systems, artificially engineered biomarker detection systems (clinical biosensors) also struggle with the presence of spurious molecules in bodily fluids. Typically, these clinical biosensors have a sensing surface coated with receptor molecules which are obtained in the form of antibodies produced in vivo against the biomarker of interest. Therefore, the binding affinity of the receptors towards the biomarker is higher than other biomolecules in the serum. However, because of the in-vivo selection process, these receptors are also often cross-reactive. Even though these antibodies are screened only against the biomarker of interest, in many cases, they have binding affinity towards several unrelated antigens present in the serum [5] . Therefore, in a biomarker detection process one also needs to consider the noise due to the binding of spurious molecules to the receptors.
In a previous work [6] , we have calculated the limit of detection of a clinical biosensor in an experimentally relevant situation. Our analysis showed that if the concentration of the receptors is not known to infinite precision, then the choice of the read-out technique has a large effect on the performance of the biosensor, particularly the fidelity of measurement. With uncertainty in the receptor concentration, a read-out technique with minimum signal background from the unbound receptors performs better. This result explains the lower of fluorescence-based techniques such as ELISA compare to label-free techniques. With an optimal read-out technique which minimizes the background from unbound receptors, the performance of a biosensor is then limited by the fluctuation in the concentration of the spurious molecules present in the serum. The limit of detection ( ) of such a system can be written as = √2 (1) Experimental evidence suggests that this limit of detection can be significantly improved by adding a second step where a label molecule is introduced into the system. Similar to the receptors, these label molecules have a higher binding affinity towards the biomarker of interest and therefore selectively binds to them. Interestingly, addition of the second molecule in these system mimics the effect of proofreading in cellular sensing systems, even though, unlike Hopfield's proofreading schemes, all the reactions in case of the two-step diagnostic processes are in equilibrium. In this article, we derive a general expression for the limit of detection of a two-step diagnosis process. In the light of the results in our previous work, we will then limit ourselves to the analysis of fluorescence-based two-step detection techniques to study the effects of addition of a label molecule in the sensing system. We will conclude our analysis by comparing a two-step diagnosis process with traditional non-equilibrium proofreading schemes.
Mathematical model
Let us consider a two-step biomolecular detection system using a fluorescent label even though the approach here is applicable to any other labels such as enzymes in the case ELISA. The first step is to pour the serum over a surface where receptors are immobilized. Ideally, this should cause biomarkers to specifically attach to the surface. However, non-specific antigens present in the serum also get attached to the surface due to the low specificity of the receptors. Therefore, in the second step, a fluorescently labeled antibody is applied over the surface. Similar to [6] , to detect the presence of specific biomarkers in the serum, a baseline measurement is done with healthy serum and is compared with the serum to be tested. If and are the output signals from experiments in presence and absence of specific ligands respectively, then the generic expressions for and can be written as
Where is the concentration of the receptor molecules, ( ) and represent the signal due to the receptors which are bound only by the ligand molecules and receptors which are bound with both ligand molecules and labels respectively. The parameter is the measurement noise, which is defined as = , .
is the average fluorescence due to the binding of the label molecules to the sensor surface and is the variance in the measured parameter due to the noise in the measurement system.
The parameters ( ) and ( ) can be defined as
where is the dissociation constant for the ligand-fluorescent label interaction, is the dissociation constant for the ligand-receptor interaction and the subscripts , , and represent receptors, specific ligands, non-specific ligands and labels respectively. Typical biosensors have receptor concentration much larger than the specific and non-specific ligand concentrations to avoid undetectability in presence of measurement noise [6] . Therefore, the expression for ( ) and ( ) in equation (3) can be rewritten as
Similar to [6] , to consider the effects of the fluctuations in the concentrations of receptor and non-specific ligand molecules, we have assumed and as Gaussian distributions defined as = 1 + (0, )
In a real-life scenario, the concentration of the fluorescent labels depends on the probability that a label molecule is tagged with the fluorescent molecules. However, it is always possible to eliminate the noise generated by the stochasticity of tagging by selecting only the tagged molecules. Therefore, without loss of generality, we can safely assume the concentration of label molecules ( ) to be constant. Therefore, following the derivation in [6] , the of a two-step biomarker sensor can be written as 
Results and discussion:
We can retrieve the limit of detection of a one-step detection system [6] from equation (5) for = 0. Similar to the one-step detection system, the limit of detection in case of a two-step system ( ) also explicitly depends on the parameters , , and . As a result, the effects of these parameters on the limit of detection remain unchanged after the addition of the second step. In contrast, the parameter ( ) has exactly the opposite effect than it had in the one-step system. To achieve a lower limit of detection in case of a one-step system, ( ) needed to be high. Instead, in case of a two-step system, optimal limit of detection can be achieved by minimizing ( ) while maximizing ( ) . [Fig 1a] Therefore, for an optimal two-step biomarker detection system, = ( ) = 0. For such a system, the limit of detection becomes (6) is that ( ) converges to the ( ) calculated in equation (10) of [6] for ≫ .
Therefore, adding a large concentration of label molecules doesn't increase specificity of the optimal detection system. One could intuitively interpret this in the following manner. In case of ≫ , because of the abundance of the fluorescent labels, there will be no competition between the specific and non-specific ligands for binding to the labels. Therefore, the labels will bind to all the binding sites with equal probability and the assay will get saturated. On the other hand, addition of label molecules in very low concentration can improve the significantly. Comparing ( ) with derived in [6] for ≪ , we get
We can compare this result with the kinetic proofreading scheme described by Hopfield [4] . Hopfield demonstrated that the probability of formation of an error product of an equilibrium Michaelis-Menten system can be improved by addition of a non-equilibrium step. His results suggest that the maximum possible improvement in specificity in a such a system will be of the order of , where is the ratio of the dissociation constants of the correct and error reactants. Although, results in equation (7) is similar to Hopfield's results, unlike Hopfield's model, all the reaction kinetics in this case are in equilibrium. One can consider the addition of the label molecule into the system as the out-of-equilibrium step in the process as it breaks the law of conservation of mass. In fact, addition of the label molecule provides additional information and thereby decreases the entropy of the system. Therefore, the two-step diagnosis system doesn't need a non-equilibrium step to achieve a higher specificity.
Conclusion:
In [6], we had calculated the limit of detection of a one-step biomolecular detection system. We showed that under optimal experimental conditions, the is limited by the fluctuation in the concentration of the non-specific ligand molecules present in the serum. In this article we extended the analysis to two-step detection systems where a label molecule is added to the system as a second step. Our results show that addition of label molecule in small concentration can reduce the significantly as observed in commercially available systems such as ELISA. Surprisingly, addition of large concentration of label molecules results in no measurable change in the of the system.
Our analysis provides a mathematical framework for designing two-step biomarker detection systems. We demonstrated that for optimal two-step systems, the contrast between the signals due to the unbound receptors and receptors bound only in the first step of the process needs to be minimized. Therefore, detection systems that perform poorly as one-step systems, can be excellent candidates for a two-step detection system.
